Multi-Mechanistic Approaches to Disarming IgE-Mediated Allergic Diseases 2304105
The Journal of Immunology · 01.08.2026 · 215 (Supplement_1)
DOI: 10.1093/jimmun/vkag141.1270 ↗Kurz gefasst
Fachartikel in der Zeitschrift The Journal of Immunology, online erschienen am 28.07.2026. Verfasst von Purvi Mande und 19 weiteren Autor:innen.
Abstract (Originalsprache)
Introduction
Pathogenic IgE production contributes to a wide range of allergic and atopic diseases. Binding of allergen-specific IgE to its high-affinity IgE receptor FcεRI on basophils and mast cells results in allergen-mediated cross-linking of FcεRI-bound IgE triggering the release of inflammatory mediators causing allergic reactions. We briefly highlight here Seismic’s multiple approaches to rapidly disarm the allergic effector cells. These include (i) cleaving and eliminating circulating IgE, (ii) dissociating IgE from effector cells and down-modulating effector function, and (iii) sweeping IgE from circulation for clearance. Here we will focus on the discovery and design of our IgE dissociator that rapidly dissociates IgE from FcεRI on effector cell surfaces and preventing cell activation, as well as preventing binding of free IgE to FcεRI and FcεRII.
Methods
IgE dissociators, discovered from an immunization campaign, were screened by surface plasmon resonance and in primary human cell-based assays using flow cytometry for their ability to dissociate IgE from FcεRI. Confirmatory basophil activation assays were performed on human whole blood. Pharmacokinetics (PK), pharmacodynamics (PD) and in vivo efficacy were tested using relevant preclinical models.
Results
The IgE dissociator rapidly dissociates IgE from the high affinity receptor FcεRI on basophil and mast cell surfaces without triggering degranulation, and shows superior IgE dissociation and FcεRI down modulation compared to standard of care in preclinical models. It exhibits multi-pharmacology by preventing free IgE binding to FcεRI and FcεRII. It demonstrates favorable PK, PD and efficacy in murine model of acute anaphylaxis.
Conclusion
Our IgE dissociator molecules address multiple aspects of IgE pathology by rapidly removing FcεRI-bound IgE and neutralizing free IgE without triggering effector-cell activation, providing a unique and potentially more effective approach to treat IgE-driven allergic and atopic diseases. Funding Source n/a Topic Categories Immediate Hypersensitivity, Asthma, and Allergic Responses (HYP)
Zitieren
APA
Mande, P., Colthart, A., Cianci, M., Vitlip, J., Plascencia, A., Newton, A., Le, N., Wittenberg, E., Shin, J., Anderson, J., Lutz, S., Peckner, R., Sundy, J. S., Higginson-Scott, N., Xing, Y., Visweswaraiah, J., Otipoby, K. L., Mascanfroni, I., Pellerin, A., & Cipoletta, D. (2026). Multi-Mechanistic Approaches to Disarming IgE-Mediated Allergic Diseases 2304105. The Journal of Immunology, 215(Supplement_1). https://doi.org/10.1093/jimmun/vkag141.1270
Vancouver
Mande P, Colthart A, Cianci M, Vitlip J, Plascencia A, Newton A, et al. Multi-Mechanistic Approaches to Disarming IgE-Mediated Allergic Diseases 2304105. The Journal of Immunology. 2026;215(Supplement_1). doi:10.1093/jimmun/vkag141.1270
BibTeX
@article{Mande2026,
author = {Mande, Purvi and Colthart, Allison and Cianci, Mike and Vitlip, Joshua and Plascencia, Agustin and Newton, Andita and Le, Nam and Wittenberg, Elliott and Shin, Jung-Eun and Anderson, Jordan and Lutz, Stephen and Peckner, Ryan and Sundy, John S and Higginson-Scott, Nathan and Xing, Yi and Visweswaraiah, Jyothsna and Otipoby, Kevin L and Mascanfroni, Ivan and Pellerin, Alex and Cipoletta, Daniela},
title = {Multi-Mechanistic Approaches to Disarming IgE-Mediated Allergic Diseases 2304105},
journal = {The Journal of Immunology},
year = {2026},
volume = {215},
number = {Supplement_1},
doi = {10.1093/jimmun/vkag141.1270}
}
EUVIMED